Not Tagged
Not Tagged
['beat', 'aml,(-streamline),(-seamless),(-kamloops)', 'tp-0903']
program guide asco meeting program guide tp-0903 + decitabine in hr-#aml (complex cg/tp53m) early results by #beat_aml studies. the highest risk group and toughest to treat. await dose level -1 data #asco22 
Hematologist focused on myeloid diseases. views are mine